Different Original and Biosimilar TNF Inhibitors Similarly Reduce Joint Destruction in Rheumatoid Arthritis—A Network Meta-Analysis of 36 Randomized Controlled Trials
Graudal, N.; Kaas-Hansen, B.S.; Guski, L.; Hubeck-Graudal, T.; Welton, N.J.; Jürgens, G. Different Original and Biosimilar TNF Inhibitors Similarly Reduce Joint Destruction in Rheumatoid Arthritis—A Network Meta-Analysis of 36 Randomized Controlled Trials. Int. J. Mol. Sci. 2019, 20, 4350. https://doi.org/10.3390/ijms20184350
Graudal N, Kaas-Hansen BS, Guski L, Hubeck-Graudal T, Welton NJ, Jürgens G. Different Original and Biosimilar TNF Inhibitors Similarly Reduce Joint Destruction in Rheumatoid Arthritis—A Network Meta-Analysis of 36 Randomized Controlled Trials. International Journal of Molecular Sciences. 2019; 20(18):4350. https://doi.org/10.3390/ijms20184350
Chicago/Turabian StyleGraudal, Niels; Kaas-Hansen, Benjamin S.; Guski, Louise; Hubeck-Graudal, Thorbjørn; Welton, Nicky J.; Jürgens, Gesche. 2019. "Different Original and Biosimilar TNF Inhibitors Similarly Reduce Joint Destruction in Rheumatoid Arthritis—A Network Meta-Analysis of 36 Randomized Controlled Trials" Int. J. Mol. Sci. 20, no. 18: 4350. https://doi.org/10.3390/ijms20184350